KIORA PHARMACEUTICALS INC (KPRX) Executive Compensation
KIORA PHARMACEUTICALS INC (KPRX) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: KPRX
CIK: 1372514
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Haskell & White LLP
Auditor SinceSince 12/31/2023 12:00:00 AM
Lead Engagement PartnerRichard Smetanka
Audit LocationIrvine, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-09-17 | 2026-09-17 | FORM 4 | 0001372514-26-000085 | View SEC Doc Filr Page |
| 3 | 2026-09-17 | 2026-09-08 | FORM 3 | 0001372514-26-000083 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-09-17 | — | SCHEDULE 13G Filing | 0001957912-26-000030 | View SEC Doc Filr Page |
| 8-K | 2026-09-08 | 2026-09-08 | 8-K | 0001372514-26-000079 | View SEC Doc Filr Page |
| 8-K | 2026-08-19 | 2026-08-19 | 8-K | 0001372514-26-000077 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001104659-26-097323 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001104659-26-097279 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-10 | — | SCHEDULE 13G Filing | 0001193125-26-341731 | View SEC Doc Filr Page |
| 8-K | 2026-08-07 | 2026-08-07 | 8-K | 0001372514-26-000075 | View SEC Doc Filr Page |
| 10-Q | 2026-08-07 | 2026-06-30 | 10-Q | 0001372514-26-000074 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-07-01 | FORM 4 | 0001372514-26-000067 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-07-01 | FORM 4 | 0001372514-26-000065 | View SEC Doc Filr Page |
| 8-K | 2026-06-18 | 2026-06-18 | 8-K | 0001372514-26-000063 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-10 | FORM 4 | 0001861519-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-10 | FORM 4 | 0001855207-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-10 | FORM 4 | 0001895795-26-000001 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-10 | FORM 4 | 0001793796-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-10 | FORM 4 | 0001711576-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-10 | FORM 4 | 0001372514-26-000061 | View SEC Doc Filr Page |
| 8-K | 2026-06-11 | 2026-06-10 | 8-K | 0001372514-26-000059 | View SEC Doc Filr Page |
| 424B3 | 2026-05-28 | — | 424B3 | 0001372514-26-000057 | View SEC Doc Filr Page |
| EFFECT | 2026-05-22 | — | EFFECT Filing | 9999999995-26-001753 | View SEC Doc Filr Page |
| CORRESP | 2026-05-20 | — | CORRESP Filing | 0001372514-26-000053 | View SEC Doc Filr Page |
| UPLOAD | 2026-05-20 | — | UPLOAD Filing | 0000000000-26-005167 | View SEC Doc Filr Page |
| S-3 | 2026-05-18 | — | S-3 | 0001372514-26-000050 | View SEC Doc Filr Page |